search
Back to results

Development of an Adaptive Treatment for Weight Loss in People With Prediabetes

Primary Purpose

PreDiabetes, Obesity

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
High Carbohydrate Diet
Reduced Carbohydrate Diet
Sponsored by
University of Alabama at Birmingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for PreDiabetes focused on measuring weight loss, reduced carbohydrate diet, exercise training, time restricted eating

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 18-75 years of age
  • BMI of 27 kg/m2 or greater
  • at risk for developing type 2 diabetes (prediabetes)

Exclusion Criteria:

  • Pregnant, planning to become pregnant, or breastfeeding
  • uncontrolled hypo or hyperthyroidism

Sites / Locations

  • UAB Highlands Family and Community Medicine Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

High Carbohydrate Diet

Reduced Carbohydrate Diet

Arm Description

Enrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with high carbohydrate diet plan.

Enrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with reduced carbohydrate diet plan.

Outcomes

Primary Outcome Measures

Changes in body weight
Measured on digital scale in order to determine "responder" or "non-responder" status.
Changes in body weight
Measured on digital scale at final visit.
Change in glucose
Serum glucose will be measured in a fasted state.
Change in insulin
Serum insulin will be measured in a fasted state.
Changes in lipids
Fasting serum concentrations of total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol
Changes in fat mass
As measured by bioelectrical impedance analysis (BIA) on the InBody S10 body composition analyzer.
Changes in QUICKI index
Predictor of insulin resistance that will be calculated from glucose and insulin measures

Secondary Outcome Measures

Changes in overall strength
As measured by hand grip dynamometry
Changes in aerobic fitness
As measured by the 3-minute step test.
Diet Intake and Physical Activity Monitoring
7-day food logs and weekly physical activity logs
Diet Intake and Physical Activity Monitoring
7-day food logs and weekly physical activity logs

Full Information

First Posted
February 4, 2021
Last Updated
July 13, 2023
Sponsor
University of Alabama at Birmingham
Collaborators
General Mills
search

1. Study Identification

Unique Protocol Identification Number
NCT04745572
Brief Title
Development of an Adaptive Treatment for Weight Loss in People With Prediabetes
Official Title
Development of an Adaptive Treatment Strategy for Weight Loss in People With Prediabetes Using a Sequential Multiple Assignment Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 14, 2021 (Actual)
Primary Completion Date
December 1, 2023 (Anticipated)
Study Completion Date
December 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alabama at Birmingham
Collaborators
General Mills

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This 16-week study will use an experimental approach called the Sequential Multiple Assignment Randomized Trial to help determine which combination and sequence of weight loss program features are most effective in people who are at risk for type 2 diabetes. Participants in the study will be initially randomized to consume either a high or reduced carbohydrate diet. After 4 weeks, participants will be identified as Responders (greater than or equal to 2.5% weight loss) or Non-Responders (less than 2.5% weight loss). Responders will continue with their initial randomized group for the remainder of the trial. Non-responders will be re-randomized to 2nd stage interventions of either including additional exercise counseling and training or beginning a time restricted eating protocol for the remainder of the trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PreDiabetes, Obesity
Keywords
weight loss, reduced carbohydrate diet, exercise training, time restricted eating

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
90 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High Carbohydrate Diet
Arm Type
Experimental
Arm Description
Enrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with high carbohydrate diet plan.
Arm Title
Reduced Carbohydrate Diet
Arm Type
Experimental
Arm Description
Enrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with reduced carbohydrate diet plan.
Intervention Type
Behavioral
Intervention Name(s)
High Carbohydrate Diet
Intervention Description
Participants randomized to this group will participate in a group-based weight behavioral management program and consume a high carbohydrate (HC) diet. Because this protocol uses a sequential, multiple assignment, randomized trial (SMART) design, response will be assessed at week 4. Responders will continue with their 1st stage assignment for the remainder of the study. Non-responders will be randomized to 2nd stage intervention of either combine HC diet with time-restricted eating (TRE) or HC diet with additional exercise counseling and support.
Intervention Type
Behavioral
Intervention Name(s)
Reduced Carbohydrate Diet
Intervention Description
Participants randomized to this group will participate in a group-based behavioral weight management program and consume a reduced carbohydrate (RC) diet. Because this is a sequential, multiple assignment, randomized trial (SMART) design, response will be assessed at week 4. Responders will continue with their 1st stage assignment for the remainder of the study. Non-responders will be randomized to 2nd stage intervention of either combine RC diet with time-restricted eating (TRE) or RC diet with additional exercise counseling and support.
Primary Outcome Measure Information:
Title
Changes in body weight
Description
Measured on digital scale in order to determine "responder" or "non-responder" status.
Time Frame
week 4 visit
Title
Changes in body weight
Description
Measured on digital scale at final visit.
Time Frame
week 16 visit
Title
Change in glucose
Description
Serum glucose will be measured in a fasted state.
Time Frame
week 16 visit
Title
Change in insulin
Description
Serum insulin will be measured in a fasted state.
Time Frame
week 16 visit
Title
Changes in lipids
Description
Fasting serum concentrations of total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol
Time Frame
week 16 visit
Title
Changes in fat mass
Description
As measured by bioelectrical impedance analysis (BIA) on the InBody S10 body composition analyzer.
Time Frame
week 16 visit
Title
Changes in QUICKI index
Description
Predictor of insulin resistance that will be calculated from glucose and insulin measures
Time Frame
week 16 visit
Secondary Outcome Measure Information:
Title
Changes in overall strength
Description
As measured by hand grip dynamometry
Time Frame
week 16 visit
Title
Changes in aerobic fitness
Description
As measured by the 3-minute step test.
Time Frame
week 16 visit
Title
Diet Intake and Physical Activity Monitoring
Description
7-day food logs and weekly physical activity logs
Time Frame
week 4 visit
Title
Diet Intake and Physical Activity Monitoring
Description
7-day food logs and weekly physical activity logs
Time Frame
week 16 visit

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18-75 years of age BMI of 27 kg/m2 or greater at risk for developing type 2 diabetes (prediabetes) Exclusion Criteria: Pregnant, planning to become pregnant, or breastfeeding uncontrolled hypo or hyperthyroidism
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Holly Wyatt, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
Facility Information:
Facility Name
UAB Highlands Family and Community Medicine Clinic
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35205
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Development of an Adaptive Treatment for Weight Loss in People With Prediabetes

We'll reach out to this number within 24 hrs